ARTIFICIAL INTELLIGENCE (AI) IN BIOTECHNOLOGY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Artificial Intelligence (AI) in Biotechnology Market, By Component (Software, Hardware, Services), By Application (Drug Discovery & Development, Clinical Trials & Optimization, Medical Imaging, Diagnostics, Others), By End User (Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes, Healthcare Providers, CRO & CDMO, Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

In June 2023, Sanofi, a France-based multinational pharmaceutical and healthcare company, announced a significant advancement in its digital transformation with the widespread rollout of "plai," an innovative app developed in collaboration with Aily Labs, a AI platform company. The app is designed to revolutionize data interaction by offering real-time insights and a comprehensive view of Sanofi's operations.
In August 2022, Atomwise, a biotechnology company, and Sanofi announced collaboration to employ the latter's artificial intelligence (AI)-powered AtomNet platform for computational drug target discovery and research on up to five different targets
In June 2022, ACTO, a commercial learning platform tailored for the life sciences sector, introduced "LAICA," a conversational assistant powered by artificial intelligence (AI). This innovative tool offers a voice-enabled search feature designed to support real-time learning for teams in life sciences commercial and medical affairs.